Court deals setback to FTC fight against "pay for delay" agreements

04/27/2012 | National Law Journal (free registration), The

The U.S. Court of Appeals for the 11th Circuit has struck a blow to the Federal Trade Commission's goal of stopping "pay for delay" deals. Such deals involve makers of brand-name pharmaceuticals paying other companies to refrain from making generic drugs. The court found that a deal between drug companies involving the testosterone treatment AndroGel did not run afoul of federal antitrust laws.

View Full Article in:

National Law Journal (free registration), The

Published in Brief: